Anxiety Disorders Completed Phase 4 Trials for Venlafaxine (DB00285)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00183274Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XRTreatment
NCT00546923Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious PatientsTreatment